# Innomed Ventures

> Innomed Ventures is a VC fund in Jerusalem backing Health Care, Medical and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Jerusalem, Israel
- Total investments: 3
- Last investment: May 2014
- Lead investor: 0%
- Last updated: Aug 2026

Innomed Ventures is a VC fund in Jerusalem focused on Health Care and Medical. Innomed Ventures provides later-stage venture investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Medical | 2 | 67% |
| Biotechnology | 2 | 67% |
| Medical Device | 2 | 67% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Israel | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Impliant | Impliant Ltd. and over $50 million have been invested in laboratory testing and clinical work to perfect the implant, the instrumentation, and the surgical technique. The TOPS(TM) System aims to revolutionize the spinal implant market in much the same way that total hip and total knee replacement systems displaced hip and knee fusions. PremiaSpine's singular focus today is to provide patients and surgeons with a clinically-proven superior solution to lumbar fusion surgery. | $7M |  | May 29, 2014 |  |
| AngioScore | AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element. | $15M | Series B | Aug 23, 2004 |  |
| ForeseeHome | Notal Vision is developing the first comprehensive diagnostic solution for the early detection and frequent monitoring of Age-Related Macular Degeneration (AMD), the leading cause of blindness in the western world today. Early detection of ARM can allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight. A truepioneer in the eye care industry, Notal Vision has developed and introduced the first home-based monitoring system for AMD patients, the ForeseeHome™ AMD Monitoring Program. | $4M | Series A | Jan 27, 2003 |  |

3 of 3 investments shown.

## Co-investors
- [7 Health Ventures](https://shizune.co/investors/profile/7-helath-ventures) — VC Fund, 1 deal together
- [Advent International](https://shizune.co/investors/profile/advent-international) — VC Fund, 1 deal together
- [California Technology Ventures](https://shizune.co/investors/profile/california-technology-ventures) — VC Fund, 1 deal together
- [Elron Ventures](https://shizune.co/investors/profile/elron-electronic-industries) — VC Fund, 1 deal together
- [Gemini Israel Ventures](https://shizune.co/investors/profile/gemini-israel-funds) — VC Fund, 1 deal together
- [Pelion Venture Partners](https://shizune.co/investors/profile/pelion-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)

## FAQ

### What does Innomed Ventures invest in?

Innomed Ventures invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Innomed Ventures last invest?

The most recent investment recorded for Innomed Ventures closed in May 2014. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co